Nj. Wald et al., SERUM SCREENING FOR DOWNS-SYNDROME BETWEEN 8 AND 14 WEEKS OF PREGNANCY, British journal of obstetrics and gynaecology, 103(5), 1996, pp. 407-412
Objective To determine the value of serum screening for Down's syndrom
e at 8-14 weeks of pregnancy using seven potential serum markers (alph
a-fetoprotein, unconjugated oestriol, total human chorionic gonadotrop
hin (hCG), free alpha-hCG, free beta-hCG, pregnancy associated plasma
protein A (PAPP-A), and dimeric inhibin A). Design Stored blood sample
s collected from women at about 10 weeks of pregnancy, prior to having
a chorionic villus sampling procedure on account of advanced maternal
age, were retrieved from pregnancies associated with Down's syndrome
and from matched unaffected pregnancies. Setting Twenty-one obstetric
centres in nine countries. Subjects Seventy-seven pregnancies associat
ed with Down's syndrome each matched with five controls (except in two
cases that were matched with four controls) for maternal age (same fi
ve year age groups), duration of storage of the serum sample (same cal
endar year), and gestational age (usually same week of pregnancy). Res
ults The levels of two potential markers differed between affected and
unaffected pregnancies sufficiently to be of value in screening-free
beta-hCG and PAPP-A. The median free beta-hCG level in affected pregna
ncies was 1.79 times the median level for unaffected pregnancies, and
the median PAPP-A level was 0.43 times the normal median. These two ma
rkers were combined with maternal age to estimate a woman's risk of ha
ving a fetus with Down's syndrome. A screening programme that used a r
isk cutoff level of 1:300 would detect 63% of affected pregnancies and
also classify 5.5% of unaffected pregnancies as screen positive. None
of the other five markers added more than 2% detection for the same f
alse-positive rate. Conclusion The performance of screening using mate
rnal age and serum-free beta-hCG and PAPP-A at 10 weeks of pregnancy w
as better than the double test (alpha-fetoprotein and hCG with materna
l age) and similar to the triple test (alpha-fetoprotein, unconjugated
oestriol and hCG with maternal age) at 15-22 weeks.